Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide.
Future Med Chem
; 11(23): 3005-3013, 2019 12.
Article
en En
| MEDLINE
| ID: mdl-31710246
Aim: To research the synergistic activity of G2-S16 dendrimer and dapivirine (DPV) antiretroviral as microbicide candidate to prevent HIV-1 infection. Materials & methods: We assess the toxicity of DPV on cell lines by MTT assay, the anti-HIV-1 activity of G2-S16 and DPV alone or combined at several fixed ratios. Finally, their ability to inhibit the bacterial growth in vitro was assayed. The analysis of combinatorial effects and the effective concentrations were performed with CalcuSyn software. Conclusion: Our results represent the first proof-of-concept study of G2-S16/DPV combination to develop a safe microbicide.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pirimidinas
/
Silanos
/
VIH-1
/
Fármacos Anti-VIH
/
Células Epiteliales
/
Dendrímeros
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Future Med Chem
Año:
2019
Tipo del documento:
Article
País de afiliación:
España
Pais de publicación:
Reino Unido